Literature DB >> 32224502

Immune reconstruction inflammatory syndrome in HIV infection: beyond what meets the eye.

Irini Sereti1.   

Abstract

A high proportion of individuals with HIV infection currently are diagnosed at an advanced stage of disease (late presenters), increasing their risk for immune reconstitution inflammatory syndrome (IRIS). IRIS typically occurs within 6 months of initiation of antiretroviral therapy (ART) in patients with low CD4+ cell counts and can occur before any marked elevation in CD4+ count is achieved on ART. In addition to low CD4+ count at ART initiation, 2 other major clinical predictors of IRIS are preexisting opportunistic infection (including subclinical infection) and shorter treatment period for opportunistic infection prior to starting ART. Mycobacterial infection-associated IRIS, including tuberculosis (TB)-associated IRIS, and cryptococcal infection-associated IRIS are the most common forms of the syndrome. Corticosteroid prophylaxis and early treatment can be effective in reducing incidence of TB-IRIS and severity of symptoms in select patients. Sterilization of the cerebrospinal fluid should be achieved prior to starting ART in patients with TB meningitis and cryptococcal meningitis. This article summarizes a presentation by Irini Sereti, MD, MHS, at the International Antiviral Society-USA (IAS-USA) continuing education program held in Washington, DC, in April 2019.

Entities:  

Year:  2020        PMID: 32224502      PMCID: PMC7162680     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN: 2161-5853


  18 in total

1.  A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRIS.

Authors:  Denise C Hsu; Kimberly F Faldetta; Luxin Pei; Virginia Sheikh; Netanya S Utay; Gregg Roby; Adam Rupert; Anthony S Fauci; Irini Sereti
Journal:  Clin Infect Dis       Date:  2015-09-22       Impact factor: 9.079

2.  Immune Reconstitution Inflammatory Syndrome as a Posttransplantation Complication in Primary Immunodeficiency With Disseminated Mycobacterium avium.

Authors:  Maura Manion; Dimana Dimitrova; Luxin Pei; Juan Gea-Banacloche; Adrian Zelazny; Andrea Lisco; Christa Zerbe; Alexandra F Freeman; Steven M Holland; Christopher G Kanakry; Jennifer A Kanakry; Irini Sereti
Journal:  Clin Infect Dis       Date:  2020-02-03       Impact factor: 9.079

Review 3.  Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none.

Authors:  Daniel L Barber; Bruno B Andrade; Irini Sereti; Alan Sher
Journal:  Nat Rev Microbiol       Date:  2012-01-09       Impact factor: 60.633

4.  Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy.

Authors:  Megan Crane; Ben Oliver; Gail Matthews; Anchalee Avihingsanon; Sasiwimol Ubolyam; Vesna Markovska; J Judy Chang; Gregory J Dore; Patricia Price; Kumar Visvanathan; Martyn French; Kiat Ruxrungtham; Sharon R Lewin
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

5.  Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.

Authors:  David R Boulware; David B Meya; Conrad Muzoora; Melissa A Rolfes; Katherine Huppler Hullsiek; Abdu Musubire; Kabanda Taseera; Henry W Nabeta; Charlotte Schutz; Darlisha A Williams; Radha Rajasingham; Joshua Rhein; Friedrich Thienemann; Melanie W Lo; Kirsten Nielsen; Tracy L Bergemann; Andrew Kambugu; Yukari C Manabe; Edward N Janoff; Paul R Bohjanen; Graeme Meintjes
Journal:  N Engl J Med       Date:  2014-06-26       Impact factor: 91.245

6.  The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.

Authors:  Kogieleum Naidoo; Nonhlanhla Yende-Zuma; Nesri Padayatchi; Kasavan Naidoo; Niraksha Jithoo; Gonasagrie Nair; Sheila Bamber; Santhana Gengiah; Wafaa M El-Sadr; Gerald Friedland; Salim Abdool Karim
Journal:  Ann Intern Med       Date:  2012-09-04       Impact factor: 25.391

7.  Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.

Authors:  Anne F Luetkemeyer; Michelle A Kendall; Mulinda Nyirenda; Xingye Wu; Prudence Ive; Constance A Benson; Janet W Andersen; Susan Swindells; Ian M Sanne; Diane V Havlir; Johnstone Kumwenda
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

8.  Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.

Authors:  Graeme Meintjes; Cari Stek; Lisette Blumenthal; Friedrich Thienemann; Charlotte Schutz; Jozefien Buyze; Raffaella Ravinetto; Harry van Loen; Amy Nair; Amanda Jackson; Robert Colebunders; Gary Maartens; Robert J Wilkinson; Lutgarde Lynen
Journal:  N Engl J Med       Date:  2018-11-15       Impact factor: 91.245

9.  The tuberculosis-associated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research.

Authors:  Naomi F Walker; Cari Stek; Sean Wasserman; Robert J Wilkinson; Graeme Meintjes
Journal:  Curr Opin HIV AIDS       Date:  2018-11       Impact factor: 4.283

10.  Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions.

Authors:  Lewis J Haddow; Robert Colebunders; Graeme Meintjes; Stephen D Lawn; Julian H Elliott; Yukari C Manabe; Paul R Bohjanen; Somnuek Sungkanuparph; Philippa J Easterbrook; Martyn A French; David R Boulware
Journal:  Lancet Infect Dis       Date:  2010-11       Impact factor: 25.071

View more
  4 in total

1.  Cryptococcus neoformans-astrocyte interactions: effect on fungal blood brain barrier disruption, brain invasion, and meningitis progression.

Authors:  Yeon Hwa Woo; Luis R Martinez
Journal:  Crit Rev Microbiol       Date:  2021-01-21       Impact factor: 7.624

2.  Translocated microbiome composition determines immunological outcome in treated HIV infection.

Authors:  Krystelle Nganou-Makamdop; Aarthi Talla; Ashish Arunkumar Sharma; Sam Darko; Amy Ransier; Farida Laboune; Jeffrey G Chipman; Gregory J Beilman; Torfi Hoskuldsson; Slim Fourati; Thomas E Schmidt; Sahaana Arumugam; Noemia S Lima; Damee Moon; Samuel Callisto; Jordan Schoephoerster; Jeffery Tomalka; Peter Mugyenyi; Francis Ssali; Proscovia Muloma; Patrick Ssengendo; Ana R Leda; Ryan K Cheu; Jacob K Flynn; Antigoni Morou; Elsa Brunet-Ratnasingham; Benigno Rodriguez; Michael M Lederman; Daniel E Kaufmann; Nichole R Klatt; Cissy Kityo; Jason M Brenchley; Timothy W Schacker; Rafick P Sekaly; Daniel C Douek
Journal:  Cell       Date:  2021-07-07       Impact factor: 66.850

Review 3.  Indole Propionic Acid, an Unusual Antibiotic Produced by the Gut Microbiota, With Anti-inflammatory and Antioxidant Properties.

Authors:  Dereje Abate Negatu; Martin Gengenbacher; Véronique Dartois; Thomas Dick
Journal:  Front Microbiol       Date:  2020-10-27       Impact factor: 5.640

4.  Visceral Leishmaniasis and Herpes Zoster as a Component of Syndrome of Immune Reconstitution Inflammatory Syndrome in an HIV-Positive Patient.

Authors:  Ermira Muço; Arta Karruli; Neada Hoxha; Alma Hoxhaj; Majlinda Kokici
Journal:  Case Rep Infect Dis       Date:  2022-03-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.